hta informing innovative drugs' market access in lmics
Published Streamed 2 years ago • 458 plays • Length 1:13:30Download video MP4
Download video MP3
Similar videos
-
1:13:30
hta informing innovative drugs' market access in lmics
-
20:59
introduction to health technology assessment (hta)
-
58:39
who europe's access to novel medicines platform and support for hta in the who european region
-
3:26
what are the differences in health technology assessment (hta) across europe?
-
50:43
is there potential for a joint hta in europe: an evaluation of eunethta jca vs national app
-
1:08:10
mpe agm 2020 - webinar on reimbursement and health technology assessment (hta) in europe
-
11:06
implementation of regulation eu 2021:2282 on health technology assessment
-
6:21
health technology assessment in 6 minutes
-
4:15
understanding differences in health technology assessment (hta) across europe
-
56:40
optimizing market access for medical devices
-
1:00:22
the health technology assessment (hta) webinar
-
0:38
value of in-trial interview data for regulatory & health technology assessment (hta) decision-making
-
1:16:35
digital medicine, genetic information, and health technology assessment
-
9:38
health technology assessment methods for research oriented market access - ihe presentation at smdm
-
1:58
health technology assessment
-
57:21
are you ready for the new eu hta in 2025? | market access webinar
-
23:25
2nd health innovation conference_edith frénoy, director of market access/hta, efpia
-
1:06
differences in global health technology assessment